FUTHAN

This brand name is authorized in Japan

Active ingredients

The drug FUTHAN contains one active pharmaceutical ingredient (API):

1 Nafamostat UNII 1D2T74921W - NAFAMOSTAT MESYLATE
Read about Nafamostat

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AE	Direct thrombin inhibitors	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents
Discover more medicines within B01AE

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999407D1181, 3999407D2021

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.